In this scenario, several molecules involved in both EMT and bone mineralization, such as vimentin, bone morphogenetic proteins (BMPs), RANKL, and SDF-1 have been proposed as possible prognostic biomarkers of breast cancer. This evidence concerns the gene CLN5 and breast carcinoma.